Bracket Releases IRT Solution
Bracket, a clinical trial technology and specialty services provider, announced the release of CUBETM, a transformative interactive response technology (IRT) solution for the life sciences industry.
The solution leverages an iterative user acceptance build experience, which allows a UAT process that study teams can visualize during the kick off meeting. Features include:
Accelerate times for sponsors and improves efficiency for CROs
Leverages Bracket's RTSM platform, but streamlines deployment through automation
Rapid project lifecycle lets sponsors experience the system prior to requirements approval
Reduce lengthy turnaround times for enhancements and in-study changes
Read the full release here.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
